Professor, Surgery, Mayo Medical School
General Surgery
Dr. Mark D. Stegall, MD
|
|
Give Review
Dr. Mark D. Stegall is an expert in the field of General Surgery. He studied medicine at Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a top medical college. Columbia University College of Physicians & Surgeons is ranked 8 in research and 52 in primary care medicine He has 1 awards "Fellow (FACS)". Mark Stegall is also a published doctor. He has 77 paper published. The most recent paper is: Decreased chronic cellular and antibody-mediated injury in the kidney following simultaneous liver-kidney transplantation. Mark Stegall accepts Medicare.
Publications
- Decreased chronic cellular and antibody-mediated injury in the kidney following simultaneous Liver-kidney transplantation.
- Compensatory hypertrophy of the remaining kidney in medically complex living kidney donors over the long term.
- Through a glass darkly: seeking clarity in preventing late kidney transplant failure.
- Antibody-mediated rejection despite inhibition of terminal complement.
- New insights regarding chronic antibody-mediated rejection and its progression to transplant glomerulopathy.
- Kidney donors at increased risk? Additional studies are needed.
- Renal retransplantation after kidney and pancreas transplantation using the renal vessels of the failed alloGraft: pitfalls and pearls.
- Assessing the Efficacy of Kidney Paired Donation-Performance of an Integrated Three-Site Program.
- Urine But Not Serum Soluble Urokinase Receptor (suPAR) May Identify Cases of Recurrent FSGS in Kidney Transplant Candidates.
- Living donor kidney transplantation using laparoscopically procured multiple renal artery kidneys and right kidneys.
- Oral paricalcitol reduces the prevalence of posttransplant Hyperparathyroidism: results of an open label randomized trial.
- Acute pancreas alloGraft rejection is associated with increased risk of Graft failure in pancreas transplantation.
- Urine high and low molecular weight proteins one-year post-kidney transplant: relationship to histology and Graft survival.
- Inter and intra laboratory concordance of HLA antibody results obtained by single antigen bead based assay.
- Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades.
- Five-year outcomes in living donor kidney transplants with a positive crossmatch.
- The role of complement in antibody-mediated rejection in kidney transplantation.
- Free Fatty Acid Storage in Human Visceral and Subcutaneous Adipose Tissue: Role of Adipocyte Proteins.
- An Important Debate.
- Association of kidney function and metabolic risk factors with density of glomeruli on renal biopsy samples from living donors.
- The impact of proteasome inhibition on alloantibody-producing plasma cells in vivo.
- Abnormal circadian blood pressure pattern 1-year after kidney transplantation is associated with subsequent lower glomerular filtration rate in recipients without reje...
- The effect of coronary angiography on renal function in preemptive renal transplant candidates.
- Fibrosis with inflammation at one year predicts transplant functional decline.
- The (re)emergence of B cells in organ transplantation.
- Evidence that alloantibody is a major risk factor for Graft loss and death in living-donor liver transplantation.
- Epidemiology of infections requiring hospitalization during long-term follow-up of pancreas transplantation.
- Significance and implications of capillaritis during acute rejection of kidney alloGrafts.
- The association between age and nephrosclerosis on renal biopsy among healthy adults.
- The right kidney for the right recipient: the status of deceased donor kidney allocation reform.
- Prevalence of renal artery and kidney abnormalities by computed tomography among healthy adults.
- Deciphering antibody-mediated rejection: new insights into mechanisms and treatment.
- Clinical management of renal transplant patients with donor-specific alloantibody: the state of the art.
- Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence.
- Identifying specific causes of kidney alloGraft loss.
- Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production.
- Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation.
- Pulmonary hypertension is associated with reduced patient survival after kidney transplantation.
- Survival of patients on the kidney transplant wait list: relationship to cardiac troponin T.
- Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels.
- Kidney transplant histology after one year of continuous therapy with sirolimus compared with tacrolimus.
- Long-term benefits of pancreas transplantation.
- Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression.
- The effect of antithymocyte globulin on anti-human leukocyte antigen antibody detection assays.
- Molecular evidence of injury and inflammation in normal and fibrotic renal alloGrafts one year posttransplant.
- The rationale for the new deceased donor pancreas allocation schema.
- Diurnal blood pressure changes one year after kidney transplantation: relationship to alloGraft function, histology, and resistive index.
- Comparison of low versus high tacrolimus levels in kidney transplantation: assessment of efficacy by protocol biopsies.
- Preemptive living donor kidney transplantation: do the benefits extend to all recipients?
- Complications, resource utilization, and cost of ABO-incompatible living donor kidney transplantation.
- A Comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation.
- The development of kidney allocation policy.
- Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders.
- Improving the prediction of donor kidney quality: deceased donor score and resistive indices.
- Outcome of untreated grade II rejection on solitary pancreas alloGraft biopsy specimens.
- New onset hyperglycemia and diabetes are associated with increased cardioVascular risk after kidney transplantation.
- Conquering absolute contraindications to transplantation: positive-crossmatch and ABO-incompatible kidney transplantation.
- Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different Diseases?
- Patient and Graft outcomes from older living kidney donors are similar to those from younger donors despite lower GFR.
- ABO-incompatible kidney transplantation.
- Acute nephrotoxicity of tacrolimus and sirolimus in renal isoGrafts: differential intraGraft expression of transforming growth factor-beta1 and alpha-smooth muscle actin.
- Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.
- Pancreas transplants: experience with 232 percutaneous US-guided biopsy procedures in 88 patients.
- Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus.
- Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results.
- Tolerance for immunosuppression in organ transplantation.
- Pancreas-after-kidney transplantation: an increasingly attractive alternative to simultaneous pancreas-kidney transplantation.
- Decline in native renal function early after bladder-drained pancreas transplantation alone.
- Measured and estimated GFR in healthy potential kidney donors.
- Influence of surveillance renal alloGraft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy.
- ABO-incompatible kidney transplantation using both A2 and non-A2 living donors.
- Changes in intraGraft gene expression secondary to ischemia reperfusion after cardiac transplantation.
- Chronic renal dysfunction late after Liver transplantation.
- Prospective, randomized evaluation of a cuffed expanded polytetrafluoroethylene Graft for hemodialysis vascular access.
- Subclinical rejection in tacrolimus-treated renal transplant recipients.
- Living-donor kidney transplantation at Mayo Clinic--Rochester.
Schools
Columbia University College Of Physicians and Surgeons
Ny and Presby Hp Columbia Campus
University Of Wi Hospital and Cli
Procedures Preformed
- Appendectomy, Open
- Arteriovenous Shunt Creation
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- Embolectomy, Thrombectomy, or Vessel Exploration
- View All
Conditions Treated
- Abdominal Pain
- Atelectasis
- Cholecystitis and Gallstones
- Crohn's Disease (Regional Enteritis)
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
University of Wisconsin -
New York Presbyterian Hospital - Columbia Campus -
Columbia University College of Physicians & Surgeons
Hospital
-
Mayo Clinic - Rochester, Minnesota
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1952388829 |
| Last Name Of The Provider | STEGALL |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
|
Dr. Heidi Nelson, MD |
|
|
Dr. Judy C. Boughey, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Mark D. Fleming, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lillian Erdahl, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arman Arghami, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan M. Antiel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Terry P. Nickerson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Parham Mafi, MD |
|
|
Dr. Melanie L. Richards, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Brittany L. Murphy, MD |
|
|
Dr. Onur C. Kutlu, MD
This Doctor is OpenDoctor Recommended.
|